Antibody

135개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved135 programs
AntibodyLimited DatastaleGilead SciencesPhase 2

ZIM (Zimberelimab, Zimberelimab (ZIM))

Lung Cancer; Advanced or Metastatic Non-Small-Cell Lung Cancer · Lung Cancer

#LungCancer#Antibody#Phase2#monoclonal-antibody#AdvancedorMetastaticNon-Small-Ce+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 1

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Ziv-Aflibercept)

Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Colorectal Carcinoma · FRα

#FR#Antibody#Phase1#monoclonal-antibody#ClinicalStageIVCutaneousMelanoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 2

anti TNFa monoclonal antibody - Infliximab (anti TNFa monoclonal antibody - Infliximab)

Endometriosis · Endometriosis

#Endometriosis#Antibody#Phase2#monoclonal-antibody#Janssen
Trials 1Status Active
AntibodyLimited DatastaleIsofol Medical ABPhase 2

ARFOX + bevacizumab (arfolitixorin, arfolitixorin (ARFOX + bevacizumab))

Metastatic Colorectal Cancer (mCRC) · Metastatic Colorectal Cancer (mCRC)

#MetastaticColorectalCancermCRC#Antibody#Phase2#monoclonal-antibody#Isofol
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 3

KDD (carfilzomib/daratumumab/dexamethasone, carfilzomib/daratumumab/dexamethasone (KDD))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#Janssen
Trials 1Status Discontinued
AntibodyLimited DatastaleSaglik Bilimleri UniversitesiPreclinical

ranibizumab (Lucentis, dexamethasone implant versus ranibizumab)

Diabetic Macular Edema; Inflammation · Diabetic Macular Edema

#DiabeticMacularEdema#Antibody#Preclinical#monoclonal-antibody#Inflammation+1
Trials 1Status Active
AntibodyLimited DatastaleBeijing HospitalPhase 2

irinotecan, cetuximab, envafolimab (irinotecan, cetuximab, envafolimab)

RAS Mutation; Metastatic Colorectal Cancer · RAS Mutation

#RASMutation#Antibody#Phase2#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversitätsklinikum Hamburg-Ep…Phase 3

Isa-KD (isatuximab/carfilzomib/dexamethasone, isatuximab/carfilzomib/dexamethasone (Isa-KD))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#Universittsklinikum
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

ixabepilone + cetuximab (ixabepilone + cetuximab)

Triple Negative Locally Advanced Non-resectable Breast Cancer; Metastatic Breast Cancer · Triple Negative Locally Advanced Non-res

#TripleNegativeLocallyAdvancedNon#Antibody#Phase2#monoclonal-antibody#MetastaticBreastCancer+1
Trials 1Status Active
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

metoprolol, infliximab, etanercept, tocilizumab and/or other agents (metoprolol, infliximab, etanercept, tocilizumab and/or other agents)

Solid Tumor; Hematological Malignancy · Solid Tumor

#SolidTumor#Antibody#Phase2#monoclonal-antibody#HematologicalMalignancy+1
Trials 1Status Active
AntibodyLimited DatastaleVaccinex Inc.Phase 2

pembrolizumab (Keytruda, pepinemab + pembrolizumab)

Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) · Recurrent/Metastatic Squamous Cell Carci

#RecurrentMetastaticSquamousCellC#Antibody#Phase2#monoclonal-antibody#Recurrent+2
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, pertuzumab + trastuzumab + docetaxel)

Non Small Cell Lung Cancer Metastatic; Non Small Cell Lung Cancer Stage III · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#NonSmallCellLungCancerMetastatic+2
Trials 1Status Active
AntibodyLimited DatastaleJanssenPreclinical

response to infliximab associated with methotrexate (response to infliximab associated with methotrexate)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#monoclonal-antibody#Janssen
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 2

treme (tremelimumab, tremelimumab (treme))

Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck · Advanced Solid Tumors & Metastatic Squam

#AdvancedSolidTumorsMetastaticSqu#Antibody#Phase2#monoclonal-antibody#AstraZeneca
Trials 1Status Active
AntibodyLimited DatastaleAstraZenecaPhase 2

tremelimumab+MEDI4736 (tremelimumab+MEDI4736)

Metastatic Pancreatic Ductal Adenocarcinoma · Metastatic Pancreatic Ductal Adenocarcin

#MetastaticPancreaticDuctalAdenoc#Antibody#Phase2#monoclonal-antibody#AstraZeneca
Trials 1Status Active

7 / 7 pages

← PreviousNext →